Integration of woodchuck hepatitis and N‐myc rearrangement determine size and histologic grade of hepatic tumors
暂无分享,去创建一个
M. Buendia | J. Jacob | B. Tennant | J. Gerin | P. Cote | B. Korba | A. Yeager | I. Toshkov | Á. Sterczer
[1] Chien-Jen Chen,et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.
[2] J. Grisham. Atlas of Tumor Pathology: Tumors of the Liver and Intrahepatic Bile Ducts , 2002 .
[3] P. Schirmacher,et al. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis , 2001, British Journal of Cancer.
[4] B. Pützer,et al. Large nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes. , 2001, Journal of the National Cancer Institute.
[5] B. Tennant. Animal models of hepadnavirus-associated hepatocellular carcinoma. , 2001, Clinics in liver disease.
[6] A. Kopp-Schneider,et al. Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks. , 2000, Journal of hepatology.
[7] K. Fung,et al. Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA. , 2000, Life sciences.
[8] G. Fourel,et al. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of β-catenin and synergistic effect of p53 null alleles , 2000, Oncogene.
[9] B. Tennant,et al. Treatment of chronic woodchuck hepatitis virus infection in the eastern woodchuck (marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans , 2000, Hepatology.
[10] J. Prieto,et al. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: The woodchuck animal model , 2000, Cancer Gene Therapy.
[11] M. Feitelson. Hepatitis B virus in hepatocarcinogenesis , 1999, Journal of cellular physiology.
[12] H. El‐Serag,et al. Rising Incidence of Hepatocellular Carcinoma in the United States , 1999, Infection Control & Hospital Epidemiology.
[13] G. Fourel,et al. Woodchuck Hepatitis Virus Enhancer I and Enhancer II Are Both Involved in N-myc2 Activation in Woodchuck Liver Tumors , 1998, Journal of Virology.
[14] J. Cullen,et al. Lamivudine therapy of WHV-infected woodchucks. , 1998, Virology.
[15] L Zhang,et al. Antisense Downregulation of N-myc1 in Woodchuck Hepatoma Cells Reverses the Malignant Phenotype , 1998, Journal of Virology.
[16] T. Uchiumi,et al. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. , 1997, Cancer research.
[17] J. Jacob,et al. Hepatic expression of the woodchuck hepatitis virus X‐antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X‐antigen antibody response , 1997, Hepatology.
[18] F. Zoulim,et al. Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatoma. , 1997, Journal of hepatology.
[19] M. Buendia,et al. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice , 1997, Oncogene.
[20] J. Jacob,et al. Transformation of immortalized woodchuck hepatic cell lines with the c-Ha-ras proto-oncogene. , 1996, Carcinogenesis.
[21] H. Prats,et al. Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line. , 1995, Cancer research.
[22] R. Lucito,et al. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. , 1995, The EMBO journal.
[23] F. Chisari. Hepatitis B virus transgenic mice: Insights into the virus and the disease , 1995, Hepatology.
[24] T. Tango,et al. Prospective study of chemoprevention of hepatocellular carcinoma with sho‐saiko‐to (TJ‐9) , 1995, Cancer.
[25] J. Jacob,et al. Woodchuck hepatitis virus surface antigen induces nitric oxide synthesis in hepatocytes: possible role in hepatocarcinogenesis. , 1994, Carcinogenesis.
[26] C. Rogler,et al. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. , 1993, Cancer research.
[27] D. Ganem,et al. Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses , 1993, Molecular and cellular biology.
[28] G. Fourel,et al. Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter , 1992, Molecular and cellular biology.
[29] G. Fourel,et al. Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors , 1992, Journal of virology.
[30] W. Caselmann,et al. Hepatitis B virus transactivator MHBst: activation of NF‐kappa B, selective inhibition by antioxidants and integral membrane localization. , 1992, The EMBO journal.
[31] M. Rossner. Hepatitis B virus X‐gene product: A promiscuous transcriptional activator , 1992, Journal of medical virology.
[32] C. Rogler,et al. Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry. , 1991, Carcinogenesis.
[33] Y. Dragan,et al. Facts and theories concerning the mechanisms of carcinogenesis , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] H. Varmus,et al. Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host , 1991, Journal of virology.
[35] G. Fourel,et al. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours , 1990, Nature.
[36] M. Buendia,et al. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma , 1988, Cell.
[37] B. Tennant,et al. Enzyme‐altered Liver Cell Foci in Woodchucks Infected with Woodchuck Hepatitis Virus , 1988, Japanese journal of cancer research : Gann.
[38] J. Hoofnagle,et al. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma , 1987, Hepatology.
[39] Mordecai Schwartz. A biomathematical approach to clinical tumor growth , 1961, Cancer.
[40] M. Roggendorf,et al. Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus , 2005, Journal of Cancer Research and Clinical Oncology.
[41] I. Toshkov,et al. Mucin histochemistry of virus-induced duodenal adenomas in guinea fowl , 2005, Journal of Cancer Research and Clinical Oncology.
[42] J. Bruix,et al. Hepatitis B virus and hepatocellular carcinoma. , 2003, Journal of hepatology.
[43] B. Tennant,et al. The woodchuck model of hepatitis B virus infection. , 2001, ILAR journal.
[44] H. Otto,et al. “Slow-down” of the intrahepatic bile duct development between the 2nd and the 3rd trimester of gestation , 2000 .
[45] F. X. Bosch,et al. Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.
[46] M. Makuuchi,et al. Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events. , 1999, Scandinavian journal of gastroenterology.
[47] W. Caselmann. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. , 1995, Journal of hepatology.
[48] R. Koff. Primary liver cancer: Etiological and progression factors , 1995 .
[49] M. Buendia. Hepatitis B viruses and hepatocellular carcinoma. , 1992, Advances in cancer research.
[50] R. Novak,et al. Use of the polymerase chain reaction for the sensitive detection of St. Louis encephalitis viral RNA. , 1992, Journal of virological methods.
[51] M. Buendia,et al. Evolutionary conservation of target sequences for cis-acting regulation in c-myc exon 1 and its upstream region. , 1990, Gene.
[52] A. Zuckerman,et al. Taxonomic classification of human hepatitis B virus. , 1986, Intervirology.
[53] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.